Skip to main content
logo
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.600
-0.220 (-7.80%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Virax Biolabs Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
225211-
Market Cap Growth
-21.22%-67.02%192.29%-84.34%--
Enterprise Value
-4-2-2-46-
Last Close Price
2.605.5028.5017.93173.85-

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
166.80131.40781.8410.831262.87-
PB Ratio
0.200.220.910.331.21-
P/TBV Ratio
0.270.220.880.321.21-

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
----701.38-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.060.060.070.040.02-
Net Debt / Equity Ratio
-0.83-0.83-0.72-0.67-1.040.02
Net Debt / EBITDA Ratio
1.011.010.680.57--
Net Debt / FCF Ratio
1.251.250.760.472.210.03
Asset Turnover
0.000.000.000.020.00-
Inventory Turnover
0.040.040.321.010.44-
Quick Ratio
9.569.566.4723.0110.350.02
Current Ratio
9.979.977.2725.9410.610.04
Return on Equity (ROE)
-78.65%-78.65%-114.47%-95.98%-141.63%-
Return on Assets (ROA)
-54.23%-54.23%-63.77%-50.14%-72.67%-2453.52%
Return on Capital Employed (ROCE)
-83.80%-83.80%-105.60%-115.40%-64.40%144.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-242.44%-307.75%-122.45%-397.62%-50.48%-
FCF Yield
-235.39%-298.81%-104.40%-433.98%-38.66%-
Buyback Yield / Dilution
-166.46%-166.46%-85.92%-88.76%-11.15%-
SEC Filings: 10-K · 10-Q